Contemporary cardiac resynchronization therapy (CRT) devices are equipped with reliable and extensive diagnostic and memory features yielding full disclosure of the frequency, duration, and overall ...
We report the results of a simulation of an adaptive cardiac resynchronization therapy (CRT) device performing biventricular pacing in which the atrioventricular (AV) delay and interventricular (VV) ...
DelveInsight’s Cardiac Resynchronization Therapy Market Insights report provides the current and forecast market analysis, forthcoming device innovation, individual leading cardiac resynchronization ...
Background Studies of cardiac resynchronization therapy in addition to an implantable cardioverter defibrillator in patients with mild to moderate congestive heart failure had not been shown to reduce ...
A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a ...
Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator (CRT-D) may live longer than those implanted with a traditional ...
Patients with heart failure, serious atrioventricular nodal block and recurring atrial fibrillation who are treated with cardiac resynchronization therapy using traditional single-site ventricular ...
MADIT-CRT was an influential trial that showed a reduction in heart failure complications — but not mortality — when cardiac resynchronization therapy (CRT) was added to an implantable defibrillator ...
Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital Readmissions
Data Demonstrate Clinical and Economic Value of Underutilized Treatment for Heart Failure Patients at American Heart Association's Scientific Sessions 2014 MINNEAPOLIS and CHICAGO - Medtronic, Inc.
Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval. The positive ...
To the Editor: A well-designed study aimed at showing the effect of cardiac resynchronization on mortality among patients with cardiac dyssynchrony, the Cardiac Resynchronization–Heart Failure ...
MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results